Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Status:
Completed

Trial end date:
2016-11-01

Target enrollment:

Participant gender:

Study of the what the body does to the drug in subjects with mild, moderate, and sever liver dysfunction (not working properly)

Phase 1

Sunovion